Glycogen is the primary storage form of glucose. Glycogen synthesis and breakdown are tightly controlled by glycogen synthase (GYS) and phosphorylase, respectively. The enzyme responsible for dephosphorylating GYS and phosphorylase, which results in their activation (GYS) or inactivation (phosphorylase) to robustly stimulate glycogen synthesis, is protein phosphatase 1 (PP1). However, our understanding of how PP1 recruits these substrates is limited. Here, we show how PP1, together with its muscle glycogen-targeting (G M ) regulatory subunit, recruits and selectively dephosphorylates its substrates. Our molecular data reveal that the G M carbohydrate binding module (G M CBM21 ), which is amino-terminal to the G M PP1 binding domain, has a dual function in directing PP1 substrate specificity: It either directly recruits substrates (i.e., GYS) or recruits them indirectly by localization (via glycogen for phosphorylase). Our data provide the molecular basis for PP1 regulation by G M and reveal how PP1-mediated dephosphorylation is driven by scaffolding-based substrate recruitment.
INTRODUCTION
The Ser/Thr protein phosphatase 1 (PP1) regulates diverse cellular processes, including neuronal plasticity, cell division, and protein synthesis (1). However, PP1 was originally discovered for its ability to direct glycogen metabolism in skeletal muscle. Specifically, PP1 dephosphorylates glycogen synthase, phosphorylase kinase, and glycogen phosphorylase, essential enzymes that are regulated by insulin and together control glycogen synthesis and breakdown (2) . The dephosphorylation of glycogen synthase and phosphorylase a (glycogen phosphorylase phosphorylated on Ser 14 is commonly referred to as phosphorylase a) by PP1 has opposing effects, namely, the activation of glycogen synthase and the inactivation of phosphorylase a. As a consequence, glycogen synthesis is robustly stimulated (3, 4) .
During the last 30 years, it has become apparent that PP1 associates with scores of different PP1 regulatory subunits to form distinct, heterodimeric holoenzymes (5, 6) . These PP1 regulatory subunits function to both target PP1 to its cellular point of action and selectively recruit specific substrates for PP1-mediated dephosphorylation. This latter function, substrate recruitment, is typically achieved by protein domains outside the primary PP1-anchoring domain. The ability of PP1 to regulate glycogen synthesis also requires its association with a specific regulatory subunit, the glycogen-targeting subunit in muscle, G M . Although G M was the first PP1-specific regulatory protein discovered, it is now known that it is one of seven genes in mammalian genomes that constitute the glycogen-targeting PP1 family (G-subunits): G M (R GL ) is expressed in skeletal and cardiac muscle (4, 7) ; G L (FLJ14005) is most abundantly expressed in the liver (8) ; and G C (PTG, R5) and G D (R6) are ubiquitously expressed (9) . A comprehensive molecular understanding of how these G-subunits direct both PP1 targeting and dephosphorylation of glycogen synthase and phosphorylase a is currently missing.
All G-subunits include a highly conserved RVxF motif, which is essential for PP1 binding, and a family 21 carbohydrate binding module [CBM21; also known as starch binding domains (SBDs)], which is responsible for binding glycogen (10) (11) (12) . Typically, SBDs have two sugar binding sites, known as sites 1 and 2 (13) . It is currently unknown whether only one or both of these sites in G M CBM21 are necessary for glycogen targeting. Further, it was suggested that the G M CBM21 domain may also facilitate glycogen synthase substrate recruitment (14) . However, whether or how this occurs is unknown. The first structure of PP1 bound to any of its regulators was that of PP1 bound to a short RVxF peptide from G M (15) . This structure identified the RVxF binding pocket in PP1, which showed that it is more than 20 Å away from the PP1 active site. This structure also revealed that RVxF binding does not alter the conformation of the PP1 active site, explaining why it does not affect PP1 catalytic activity. However, it did not provide any insights into whether and how G M binds to PP1 beyond the RVxF motif, how G M binds glycogen, or how these interactions facilitate glycogen-specific substrate recruitment.
Here, we used nuclear magnetic resonance (NMR) spectroscopy, x-ray crystallography, and enzymatic studies to determine how G M recruits and targets PP1 to phosphorylase a and glycogen synthase. Unexpectedly, we found that PP1 interacts with G M outside its RVxF sequence via an extended FF motif and the G M CBM21 domain; this results in extremely tight binding. After determining the structure of the G M CBM21 domain, we then used NMR chemical shift perturbation (CSP) mapping to show that only one of its two carbohydrate sites binds directly to glycogen. This led to the discovery that the second site has a different function, namely, binding and recruiting the PP1-specific substrate glycogen synthase. We then showed that while holoenzyme formation with G M does not enhance phosphorylase a dephosphorylation, the simultaneous recruitment of both G M :PP1 and phosphorylase a to glycogen does. Together, these structural and enzymatic data reveal how, at a molecular level, G M targets PP1 to its glycogen-specific substrates phosphorylase a and glycogen synthase to specifically and robustly dephosphorylate both enzymes. Thus, this study provides the most comprehensive molecular understanding of how a specific PP1 holoenzyme, G M :PP1, mediates the rapid and selective dephosphorylation of its specific substrates.
RESULTS

G M has two PP1 interaction sites
The skeletal muscle glycogen-binding subunit [PP1 regulatory subunit 3A (PPP1R3A); hereafter referred to as G M ] is a 1109-amino acid protein (124 kDa) (Fig. 1A) . It was previously shown that residues 1 to 240 are required for PP1 binding and regulation [if not otherwise noted, PP1a residues 7 to 330 (PP1a ) are used in all experiments]. Bioinformatics predicts that residues 1 to 100 are intrinsically disordered (IDR; typical for PP1 regulatory/binding regions), while residues 102 to 237 form a well-folded domain that is a member of the CBM21 family. To define the G M residues that bind directly to PP1, we used NMR spectroscopy, isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR). ITC showed that G M residues 2 to 64 do not bind PP1, as both G M 2-237 and G M 64-237 bind PP1 with the same affinities [statistically identical dissociation constant (K D ) values of 27 and 21 nM, respectively; Fig. 1 , B and C, and holoenzyme (hereafter referred to as G M :PP1) to a resolution of 1.45 Å (table S1). The structure shows that G M residues 64 to 85 become ordered when bound to PP1 ( Fig. 2A) . They bind in a largely extended manner at multiple sites across the top of PP1, including the RVxF motif binding site and the FF motif binding site (Fig. 2B) , both of which are used by a large number of PP1 interactors. The interaction between PP1 and G M is extensive, with the complex burying 2194 Å 2 of a solvent-accessible surface area. As expected for a targeting protein, the PP1 catalytic site is accessible, and PP1 is catalytically :a-CD 27,600 ± 5800 −12.7 ± 0.7 6.4 ± 0.7 −6.2 ± 0.1 3
:b-CD 8200 ± 100 −9.4 ± 0.3 2.5 ± 0.3 −6.9 ± 0.0 2 
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GM form the G M FF motif, which binds the PP1 FF binding pocket. Like the RVxF interaction, the FF interaction is highly similar to those observed in other PP1 holoenzyme complexes. Further, these residues are part of a short b strand (G M residues 78 to 81) that hydrogen bonds with PP1 b strand b14 to extend one of PP1's two central b sheets (Fig. 2C) .
Notably, a distinctive feature of the G M :PP1 holoenzyme structure is the "extended kink" between the RVxF and FF motifs (Fig. 2 , B and C). In G M , these two motifs are separated by 12 residues, the longest insert observed to date for any PP1 regulator. It is long because it forms an~8-residue "Greek key" turn. This structural feature is stabilized by two anchoring interactions: (i) a strong intermolecular bidentate salt bridge between PP1 residue Arg (Fig. 2D) Last, an overlay of the G M :PP1 holoenzyme with all other PP1 holoenzyme structures shows that the G M backbone (N to C terminus) follows a "hybrid" binding path of RepoMan (optimal overlay for the RVxF motif), PNUTS (optimal overlay from the lid motif to the FF binding pocket), and again RepoMan (optimal overlay residues from the FF motif to the C terminus; fig. S2E ). Together, this mode of interaction is typical for a scaffolding function of regulatory proteins but likely does not affect substrate selectivity toward PP1.
The G M carbohydrate binding domain also interacts with PP1 As shown by ITC, G M 64-237 binds PP1~4-fold more tightly than the primary PP1-anchoring domain (G M 64-105 ). To understand this in more detail, we determined the 3D structure of G M CBM21 (16 kDa) using solution NMR spectroscopy. The NMR data of G M CBM21 are of outstanding quality, allowing for the sequence-specific backbone assignment of 128 out of an expected 132 residues and a 98% completeness for the side-chain assignment ( fig. S3A) . A total of 2709 nuclear Overhauser effect (NOE)-based unambiguous distance restraints (~20 restraints per residue) and 110 dihedral angle restraints were used for the final structure refinement of 200 structures (table S2) . The 20 lowest-energy conformers show excellent stereochemistry, with a backbone root mean square deviation of 0.56 Å (secondary structure). G M
CBM21
, like all known SBD structures, adopts an immunoglobulinlike b-sandwich fold ( fig. S3B) (13, 20, 21) . The b-sandwich consists of nine antiparallel b strands: b0 (G M residues 108 to 110), b1 (130 to 137), b2 (144 to 151), b3 (158 to 164), b4 (174 to 178), b5 (187 to 193), b6 (208 to 215), b7 (218 to 221), and b8 (229 to 235) ( fig. S3C) . At its N terminus, G M CBM21 has an additional a helix, a1 (118 to 127). SBDs adopt one of two topologies, type I or type II, which differ in the order and orientation of a single b strand ( fig. S3D) (22) . The G M CBM21 structure adopts a type II topology; this is consistent with the observation that the majority of N-terminal SBDs adopt a type II topology, whereas most C-terminal SBDs adopt a type I topology (23) .
We then used NMR spectroscopy and GM . Mapping these residues onto the G M CBM21 structure shows that the largest changes correspond to residues within the G M CBM21 b3-b4 loop (Fig. 3 , B and C). , sugar binding site 2 forms a small narrow groove, with two protruding aromatic residues that clamp down over the sugar molecule ( fig. S3G) (20) . G M CBM21 has a similar "closed clamp" architecture at site 2, whereas G L CBM21 adopts an "open clamp" conformation. This may simply reflect the structural plasticity of site 2 (21), a site known to undergo large conformational rearrangement upon b-CD binding. These data, in addition to the presence of b0 and a1 in only G M and G L CBM21, suggest that these domains may differ in function, despite being in the same CBM21 family. alone. These data show that G M is able to bind glycogen and PP1 simultaneously, further supporting its function as a scaffolding protein.
Glycogen enhances dephosphorylation of phosphorylase a by scaffolding Substrate recruitment is poorly understood for most PP1 holoenzymes, mainly because very few substrates have been identified. This is different for the G M :PP1 holoenzyme, whose primary substrates are phosphorylase a and glycogen synthase. This enables a detailed study of the mechanism(s) by which these substrates are recruited to PP1. Phosphorylase a is phosphorylated on Ser . S6A ). Different G M constructs were used to determine how G M -interacting domains influence substrate recruitment, while the PP1-specific regulators nuclear inhibitor of protein phosphatase 1 (NIPP1) (24) and spinophilin (25) were used as negative controls [phosphorylase a is not an endogenous substrate of either the NIPP1:PP1 or the spinophilin:PP1 holoenzyme; further, previous studies showed that both holoenzymes inhibit phosphorylase a dephosphorylation (17, 26) ]. The data show that PP1 alone and all G M :PP1 holoenzymes were equally effective at dephosphorylating phosphorylase a (Fig. 4A and fig. S6B ). This demonstrates that G M CBM21 does not alter PP1's activity toward phosphorylase a. In contrast, and consistent with previous data, the PP1 binding domains from both NIPP1 and spinophilin inhibit phosphorylase a dephosphorylation.
Because phosphorylase a, like G M , binds directly to glycogen (via phosphorylase residues 397 to 437), we hypothesized that the dephosphorylation of phosphorylase a by the G M 64-237 :PP1 holoenzyme would be enhanced in the presence of glycogen. To test this, we measured phosphorylase a dephosphorylation at multiple time points in the presence and absence of glycogen. The data show that glycogen greatly enhances phosphorylase a dephosphorylation (Fig. 4B and   fig. S6C ). Thus, this leads to a model where the recruitment of both phosphorylase a and the G M 64-237 :PP1 holoenzyme to glycogen is necessary to achieve the highest dephosphorylation. To test this, we performed a glycogen pelleting assay using glycogen-bound concanavalin A (Con A)-Sepharose beads (27) . The data showed that phosphorylase a, G M
64-237
, and the G M 64-237 :PP1 holoenzyme (both alone and in combination with phosphorylase a and/or G M 64-237 ) robustly bind glycogen. In contrast, PP1 alone does not (Fig. 4C) . This demonstrates that glycogen serves as the scaffold that recruits both phosphorylase a and the G M 64-237 :PP1 holoenzyme to facilitate the G M 64-237 :PP1 holoenzyme-mediated dephosphorylation of phosphorylase a.
PP1 regulator mediated inhibition of phosphorylase a dephosphorylation PP1 has~200 confirmed distinct regulators, including G M . However, while the G M 64-237 :PP1 holoenzyme is fully capable of dephosphorylating its endogenous substrate, phosphorylase a, other PP1 regulators can inhibit PP1-mediated dephosphorylation. Previously, we found the molecular mechanism by which spinophilin prevents PP1 from dephosphorylating phosphorylase a (17). Namely, our crystal structure of the spinophilin:PP1 holoenzyme showed that spinophilin binds the PP1 C-terminal binding groove, blocking access to Asp 71 PP1 (28) . This residue is essential for phosphorylase a dephosphorylation. Thus, spinophilin and other PP1 regulators that bind the same substrate binding groove on PP1 (i.e., PNUTS) inhibit phosphorylase a dephosphorylation by steric exclusion. That is, the regulators block phosphorylase a from binding PP1 in the C-terminal groove and, as a consequence, it is not dephosphorylated. While it is well documented that NIPP1 also inhibits the dephosphorylation of phosphorylase a, the molecular mechanism by which this is achieved is still unknown (our crystal structure of the NIPP1:PP1 holoenzyme revealed that, unlike spinophilin, NIPP1 does not bind the C-terminal groove and thus Asp 71 PP1 is accessible) (26) . To further understand the molecular basis of NIPP1-mediated inhibition, we generated two chimeric PP1 regulators: NG1: NIPP1 . NG1 includes the NIPP1 helix (residues 158 to 174), the NIPP1 connector (residues 175 to 198; not visible in the NIPP1:PP1 complex crystal structure), and the full primary PP1-anchoring domain from G M (G M 64-85 ). NG2 is identical to NG1, with the exception that it does not include the NIPP1 helix ( fig. S6A ). The data show that the NG1:PP1 complex inhibits phosphorylase a dephosphorylation to the same extent as NIPP1:PP1, showing that the inhibition is due to either the NIPP1 helix or the NIPP1 linker , or both, but not the RVxF or FF interaction (i.e., G M or NIPP1 is exchangeable) (Fig. 4A and fig. S6D ). By comparison, the NG2:PP1 complex inhibits phosphorylase a dephosphorylation poorly and allows for rapid dephosphorylation similar to G M ) in the NIPP1 linker does not change inhibition significantly (26) . Thus, these data demonstrate that the NIPP1 helix is likely critical for the ability of NIPP1-mediated inhibition of PP1's ability to dephosphorylate phosphorylase a. These data correlate with those obtained for the PP1 regulator MYPT1, which has an MYPT1 helix that binds PP1 in an area similar to that of the NIPP1 helix (29) . Together these data provide insight into how the substrate phosphorylase a engages PP1 and highlights that G M does not alter PP1's activity toward phosphorylase a itself; rather, it forms a glycogen recruitment platform that allows phosphorylase a recruitment via glycogen scaffolding. :PP1 is GYS1 (muscle specific glycogen synthase; 84 kDa) (14) . GYS1 catalyzes the conversion of glucose to glycogen and is activated by two mechanisms: (i) allostery, as it is positively allosterically regulated by glucose-6-phosphate, and (ii) dephosphorylation, as the dephosphorylation of specific Ser/Thr residues increases GYS1 activity (GYS1 is phosphorylated by glycogen synthase kinase 3, AMP-activated protein kinase (AMPK), PKA, and casein kinase 2, which inhibit GYS1 activity). Dephosphorylation, which activates GYS1, is mainly controlled by PP1 via the recruitment by the G M :PP1 holoenzyme. To understand how G M :PP1 dephosphorylates GYS1, we produced functional human muscle GYS1 by coexpressing it in complex with human glycogenin-1 (GYG1; muscle specific; 66 kDa; glycogenin-1 binds directly to glycogen). Production of GYS1 in this manner results in an enzyme that is phosphorylated at both wellcharacterized and uncharacterized Ser/Thr residues (30) . Incubation of GYS1 with PP1 shows a significant shift in the migration of the GYS1 band in SDS-PAGE (polyacrylamide gel electrophoresis), as often seen when an extensively phosphorylated protein is dephosphorylated (fig. S6 , , showed a significantly larger shift, indicating that the CBM21 domain facilitates the recruitment and dephosphorylation of substrate GYS1 (Fig. 4D) .
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To identify the residues selectively dephosphorylated by the G M 64-237 :PP1 holoenzyme, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS). It is well known that the phosphorylation state of multiple residues of GYS1 is directly correlated with its activity, including residues 8 and 11 (sites 2 and 2a) and residues 641, 645, and 649 (sites 3a/b/c) (31) . We focused our analysis on Ser 641 GYS1 (3a) and Ser 645 GYS1 (3b), as the dephosphorylation of both residues is essential for GYS1 activity (sites 2 and 2a were not identified by LC-MS/MS and thus were not analyzed) ( fig. S7, A and B) . The MS data showed that only singly (3a) or doubly (3a/b) phosphorylated peptides were detected for GYS1; no unphosphorylated or singly phosphorylated (3b) peptide was observed. However S7C ). This demonstrates that this residue is rapidly dephosphorylated by all versions of PP1. In contrast, the doubly phosphorylated 3a/b peptide was most effectively dephosphorylated by the G M
64-237
:PP1 holoenzyme compared to either PP1 alone or any other PP1 holoenzymes ( fig. S7D ). This enhanced dephosphorylation by G M 64-237 : PP1 was also observed for the singly phosphorylated 3b peptide (note that this peptide is only present after incubation with PP1 or one of its holoenzymes due to the dephosphorylation of 3a) ( fig. S7E) . Further, the amount of unphosphorylated 3a/b peptide present after incubation is highest for the G M
:PP1 holoenzyme ( fig. S7F) . Last, the data also show that GYS1 phosphorylated residues that are not correlated with GYS1 activity, such as Thr 278 and Ser
412
, were not dephosphorylated by either PP1 or any of the PP1 holoenzymes (fig. S7, G and H). Together, these data show that recruitment of PP1 to the G M CBM21 via GM 64-85 creates a specific enzyme that activates GYS1 and that G M CBM21 functions as the specifier, but not any G M residue that is directly interacting with PP1.
To confirm these results, we performed two additional experiments. First, we repeated the experiment with glycogen ( fig. S8 ). In contrast to phosphorylase a, no dephosphorylation enhancement is detected upon the addition of glycogen, showing that the enhancement comes solely from G M
CBM21
. Second, we generated a G M CBM21 N228A variant, a residue that is part of a highly conserved patch of residues and was previously speculated to be involved in GYS1 recruitment (14) . Repeating the dephosphorylation assay with G M 64-237 :PP1 N228A showed a significant reduction in dephosphorylation, confirming that N228A is essential for the recruitment of GYS1 to PP1 (Fig. 4E) .
DISCUSSION
The balance between glucose storage in the form of glycogen and its subsequent breakdown is controlled by phosphorylation. A single phosphatase, the G M :PP1 holoenzyme, specifically dephosphorylates three of the key enzymes that control glycogen synthesis and breakdown: phosphorylase kinase, phosphorylase a, and glycogen synthase. While many insights into PP1 activity and function of PP1 have been obtained by studying G M :PP1, a molecular understanding of how PP1 generally and G M :PP1 in particular recruits and selectively dephosphorylates its specific substrates is still largely missing. G M :PP1 is uniquely positioned to answer these questions, as its substrates are well described. Phosphorylase a is the canonical substrate for measuring PP1 activity, and thus a detailed molecular understanding of substrate recruitment will have a profound impact on understanding PP1 regulation.
Our NMR spectroscopy, crystallography, enzymatic, and molecular binding data show that G M binds PP1 via a much longer domain than previously thought, including the canonical RVxF motif and an unusually extended FF motif that is connected by a highly structured, kinked linker. As is typical for PP1 holoenzymes, these interactions do not alter the conformation of PP1, nor do they block its active site. Thus, G M binding does not alter the catalytic activity of PP1 toward its substrates. Yet, the G M :PP1 holoenzyme is highly selective for its endogenous substrates. Previous data suggested this specificity resides in G M residues 102 to 240, which include the G M CBM21 domain. Thus, we determined the 3D structure of G M CBM21 , which showed that it belongs to the family of SBDs. Unexpectedly, using CSP mapping, we found that G M CBM21 has only one starch binding site, unlike many of its closest family members, which commonly have two (20) . This site is necessary and, as we have now shown, sufficient for the effective recruitment of glycogen. In G M , however, we show that the second starch binding site has evolved to (i) interact with PP1 and (ii) bind glycogen synthase (Fig. 5A ). These data, coupled with multiple enzymatic assays, led to the discovery that G M CBM21 achieves G M -mediated substrate recruitment via two distinct mechanisms. In the first mechanism, G M functions as a scaffold to localize PP1 near its substrates; i.e., the G M PP1 binding domain binds PP1, while the G M CBM21 domain binds glycogen. Glycogen binding, in turn, targets G M :PP1 to one of its glycogen-specific substrates, phosphorylase a (Fig. 5B) . This is because~70% phosphorylase a is always glycogen bound (32) . The phosphorylation of Ser 67 GM by PKA releases PP1 from G M (16) , leading to a model in which G M stays localized near its substrate via glycogen binding, while PP1 (via the phosphorylation state of Ser 67 GM ) is recruited only when needed. The second mechanism is direct binding between G M and a G M :PP1-specific substrate. Namely, the G M CBM21 domain binds directly to GYS1 to recruit this substrate to the G M :PP1 holoenzyme for the PP1-mediated dephosphorylation (Fig. 5C) .
As previously highlighted, phosphorylase a is also the canonical substrate used to measure PP1 activity. This has led to the discovery that many PP1-specific regulatory proteins potently inhibit PP1-mediated dephosphorylation of phosphorylase a. One of these is the PP1-specific regulator spinophilin. Using x-ray crystallography and enzymatic assays, we previously showed that spinophilin inhibits the dephosphorylation of phosphorylase a by blocking its access to the PP1 C-terminal substrate binding groove (17) . This demonstrates that regulators can achieve substrate selectivity, in part, by sterically excluding binding site for subsets of substrates. A second regulator that inhibits dephosphorylation of phosphorylase a is NIPP1. However, its structure showed that the C-terminal substrate binding groove is fully accessible, and thus, that it inhibits phosphorylase a dephosphorylation by a distinct mechanism (26) . Here, we used NIPP1-G M chimeras to show that the NIPP1 helix , which binds at the entrance of a second substrate binding groove in PP1, the hydrophobic substrate binding groove, is important for NIPP1's ability to inhibit the dephosphorylation of phosphorylase a. Thus, the NIPP1 helix likely sterically blocks the access of phosphorylase a to the PP1 hydrophobic groove. Together, these data reveal that robust dephosphorylation of phosphorylase a requires its ability to bind both the hydrophobic and the C-terminal substrate binding grooves.
This study provides the most comprehensive molecular understanding of how a specific PP1 holoenzyme, G M :PP1, mediates the rapid and selective dephosphorylation of its specific substrates. In particular, it highlights the essential role of distinct recruitment domains present in PP1-specific regulatory proteins for directing the specificity of PP1. These domains (G M CBM21 in G M ) recruit PP1 to their cellular points of action (glycogen) that, in turn, convert PP1 into an exquisitely specific enzyme, either indirectly via localizing PP1 to its specific substrates (i.e., phosphorylase a, which, like G M : PP1, also binds directly to glycogen) or directly by binding to the substrate itself (i.e., GYS1, which binds directly to G M CBM21 ). Similar mechanisms for substrate recruitment have also been observed in other PP1-specific regulators. For example, the PSD95/Discs large/ ZO-1 (PDZ) domain of the PP1-specific regulator spinophilin binds to the C termini of GluR2/3 subunits of the AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, and thus functions to localize PP1 to its specific substrate, Ser 845 of the GluR1 (33) . Likewise, the forkhead associated (FHA) domain in the regulator NIPP1 binds directly to specific substrates of the NIPP1:PP1 holoenzymes (34) . Thus, these data show that to fully understand the function of a particular PP1 holoenzyme, and especially its specificity toward distinct substrates, it is essential to understand the functions of all the domains in cognate PP1 regulatory protein. As we and others have shown, substrate recruitment sites on PPP holoenzymes are functional drug binding sites (e.g., as seen for PP2B/ PP3/calcineurin and FK-506) (35) . Thus, the identification and characterization of these specific and unique interactions, especially in PP1 holoenzymes, will lead to the design of potent, effective PP1-selective drugs.
MATERIALS AND METHODS
Protein expression
The coding sequences of rabbit G M
64-93
, G M
64-237
, and G M 2-237 were subcloned into a pET-M30-MBP vector containing an N-terminal His 6 -tag followed by maltose binding protein (MBP) and a tobacco etch virus (TEV) protease cleavage site. G M CBM21 (residues 102 to 237) was subcloned into pRP1B containing an N-terminal His 6 -tag followed by a TEV protease cleavage site. Escherichia coli strain BL21-Codon-Plus (DE3)-RIL (Agilent) cells were transformed with the G M expression vectors. Freshly transformed cells were grown at 37°C in LB medium containing selective antibiotics until they reached an OD 600 (optical density at 600 nm) of 0.8 to 1.0. Protein expression was induced by addition of 1 mM b-D-thiogalactopyranoside to the culture medium, and cultures were allowed to grow overnight (18 to 20 hours) at 18°C. Cells were harvested by centrifugation (6000g, 15 min, 4°C) and stored at −80°C until purification.
Expression of uniformly 13 C-and/or 15 N-labeled protein was carried out by growing freshly transformed cells in M9 minimal media containing [ , and G M 64-105 peptides were purchased from Bio-Synthesis Inc. G M 64-237 N228A was generated by site-directed mutagenesis and expressed using the same methods as those used for wt-G M 64-237 . The plasmid of human glycogen synthase (pFastBacDual GST-GYG1+GYS1) was a gift from E. Zeqiraj, University of Leeds. Expression and purification were carried out according to previously published methods (30) . Recombinant bacmid was generated in DH10Bac cells (Thermo Fisher Scientific) and purified using the PureLink HiPure Plasmid Maxiprep Kit (Thermo Fisher Scientific). Sf9 cells were cultured as suspension in Sf-900 III SFM medium (Thermo Fisher Scientific; 110 rpm at 26°C). P1 baculorvirus was produced in monolayer cultures by transfecting the recombinant bacmid using Cellfectin II Reagent (Thermo Fisher Scientific). P2 virus was generated by infecting Sf9 cultures (1.6× 10 6 cells/ml) with P1 virus at 400 ml per 100 ml of cells. The supernatant from P2 was harvested 3 days after infection, and 3 ml was used to infect 600 ml of Sf9 suspension culture to produce the P3 culture. P3 was used at a 1:10 ratio to infect 3 liters of Sf9 cell culture at 2.0 × 10 6 cells/ml for protein production. Cells were grown in suspension for 3 days, and the cell pellets were washed in phosphate-buffered saline before they were frozen and stored at −80°C until used.
Protein purification
, and G M 64-237 N228A cell pellets were resuspended in ice-cold lysis buffer [50 mM tris (pH 8.0), 500 mM NaCl, 5 mM imidazole, 0.1% Triton X-100, and an EDTA-free protease inhibitor tablet (Roche)] and lysed by high-pressure homogenization (Avestin EmulsiFlex C3). Lysate was clarified by centrifugation (45,000g, 45 min, 4°C), and the supernatant was loaded onto a HisTrap column (GE Healthcare) pre-equilibrated with 50 mM tris (pH 8.0), 500 mM NaCl, and 5 mM imidazole. Protein was eluted using a gradient of 5 to 500 mM imidazole. Fractions containing G M CBM21 were pooled and dialyzed overnight at 4°C against 50 mM tris (pH 8.0), 500 mM NaCl, and 0.5 mM tris(2-carboxyethyl)phosphine (TCEP) to cleave the His 6 -tag. The cleaved protein was incubated with the Ni +2 -NTA (nitrilotriacetic acid) beads (GE Healthcare) to remove the TEV protease and cleaved His-tag. The flow-through was collected, concentrated, and further purified using size exclusion chromatography [SEC; Superdex 75 26/60 (GE Healthcare)] equilibrated in NMR buffer [20 mM sodium phosphate (pH 6.5), 50 mM NaCl, and 10 mM dithiothreitol (DTT) or 20 mM bis-tris (pH 6.8), 150 mM NaCl, and 0.5 mM TCEP] or ITC buffer [20 mM tris (pH 8.0), 0.5 M NaCl, 0.5 mM TCEP, and 1 mM MnCl 2 ]. Fractions were pooled, concentrated, and stored at −20°C.
15
N-labeled G M 64-93 was purified identically except that the protein was heat purified at 95°C (15 min), and the supernatant was collected and concentrated before SEC. PP1 was purified as previously described (18) .
The GST-GYG1:GYS1 complex was purified using glutathione agarose beads (Pierce). The Sf9 cell pellet (8 g) was lysed in ice-cold lysis buffer [50 mM tris (pH 8.0), 150 mM NaCl, 5% glycerol, 1 mM EDTA, and 0.1% Triton X-100] with cOmplete mini protease inhibitor cocktail tablets (Roche). Lysate was clarified by centrifugation (40,000g, 45 min) and filtered through a 0.22-mm syringe filter. The supernatant was incubated on a rolling platform for 1 hour at 4°C with 1-ml bed volume of glutathione agarose resin pre-equilibrated in lowsalt buffer [50 mM tris (pH 8.0), 150 mM NaCl, 5% glycerol, and 1 mM EDTA]. The beads were then washed with 10 column volumes (CVs) of low-salt buffer, followed by 50 CVs of high-salt buffer [50 mM tris (pH 8.0), 500 mM NaCl, 5% glycerol, and 1 mM EDTA], and followed again by 10 CVs of low-salt buffer. The complex was eluted with 10 mM fresh reduced glutathione, concentrated to 1 mg/ml, flash frozen in liquid nitrogen, and stored at −80°C until needed. Final complex concentration was~8 mg/ml for crystallization trials using vapor diffusion (sitting drop).
NMR spectroscopy
All NMR experiments were acquired at 298 K on Bruker Avance 500 or 800 MHz spectrometers, both equipped with a TCI HCN-z cryoprobe. The following spectra were used to complete the sequencespecific backbone assignment (recorded at 500- H Larmor frequency with a saturation delay of 5 s and evaluated using the Dynamics Center 2.0 software (Bruker).
All spectra were processed using Topspin 2.1/3.0/3.1 (Bruker, Billerica, MA), and chemical shift assignments were achieved using Cara (http://cara.nmr.ch). NMR spectra of G M CBM21 were acquired using either The spectra were processed using Topspin 4.0.3 (Bruker, Billerica, MA) and analyzed using Sparky. The NMR spectra were acquired on a Bruker Avance NEO 800 MHz 1 H Larmor frequency NMR spectrometer equipped with a TCI-active HCN-cooled z-gradient cryoprobe at 298 K.
Structure calculation of G M CBM21
The following spectra were used for structure calculation:
H Larmor frequency). Automated NOESY peak picking and NOE assignment were carried out using ATNOS/ CANDID (automated NOESY peak picking/combined automated NOE assignment and structure determination module) (36) . A total of 2709 unambiguous NOESY-derived distance restraints along with 110 dihedral angle restraints derived from 13 C-chemical shifts were used in the initial structure calculations performed using CYANA (combined assignment and dynamics algorithm for NMR applications). Final energy minimization and structure refinement were performed in explicit solvent using CNS 1.3 (Crystallography and NMR system), along with the RECOORD (Recalculated Coordinates Database) script package. A total of 200 structures were generated, and the 20 conformers with the lowest restraint violation energies were selected as the final representative model. The quality of the structures was assessed by the programs WHATCHECK, AQUA (Analyzing the Quality), NMR-PROCHECK, and MOLMOL. Ramachandran analysis showed that the final bundle of 20 lowest-energy conformers of G M CBM21 has excellent stereochemistry, with 97.8% of residues in the most favored and allowed region, 2.0% in the generously allowed region, and 0.2% in the disallowed region.
CSP experiments with a-CD and b-CD The interaction of G M CBM21 with carbohydrates was tested by NMR titration experiments using a-CD (Thermo Fisher Scientific) and b-CD (Acros Organics). To this end, 2D [ 1 H, 15 N] HSQC spectra at 298 K were recorded at 500 MHz Crystallization and structure determination of the G M 64-93 :PP1a 7-300 :MC-LR complex G M 64-93 :PP1a 7-300 :MC-LR holoenzyme crystallized as clusters or single rod-shaped crystals in 0.4 M magnesium formate dihydrate and 0.1 M sodium acetate trihydrate (pH 4.6) at 4°C. For x-ray diffraction, crystals were cryoprotected in 30% glycerol and immediately flash frozen in liquid N 2 . Diffraction data were collected at the Stanford Synchrotron Radiation Lightsource beamline 12-2 at 100 K using a Dectris PILATUS 6M detector. The structure of G M 64-93 :PP1a 7-300 :MC-LR was determined by molecular replacement using Phaser as implemented in Python-based Hierarchical Environment for Integrated Xtallography (PHENIX) (37) . The PDB of PP1 (4MOV) was used as the search model. A solution was obtained in space group C222 1 . The model was completed using iterative rounds of refinement in PHENIX and manual building using Coot (Ramachandran statistics: 95.8% favored and 4.2% allowed).
Isothermal titration calorimetry ITC experiments testing the interaction between G M CBM21 and a-CD and b-CD were performed at 25°C using a VP-ITC microcalorimeter (Malvern). Both a-CD and b-CD were dissolved in 20 mM sodium phosphate (pH 6.5), 50 mM NaCl, and 10 mM DTT. Concentrations of G M CBM21 between 14.5 and 16 mM were used in the sample cell. Ligand was titrated in 10-ml increments over 20 s at concentrations of 410, 440, and 1030 mM for a-CD and 450 mM for b-CD (performed in duplicate). Twenty-eight injections were delivered during each experiment, with a 250-s interval between titrations to allow for complete equilibration and baseline recovery, and the solution in the sample cell was stirred at 307 rpm to ensure rapid mixing. To determine the thermodynamic parameters (DH, DS, and DG) and binding constant (K a ), data were analyzed with a one-site binding model assuming a binding stoichiometry of 1:1 using the Origin 7.0 software.
His 6 -tagged PP1s (PP1a 7-300 , PP1a 7-330, PP1b 6-327, PP1g 7-308, and PP1g 7-323 ) were purified as described for ITC analysis (18, 19) . G M (30 or 40 mM) was titrated into PP1 (3 or 4 mM) using a VP-ITC microcalorimeter (Malvern) or an Affinity SV ITC (TA Instruments) at 25°C. Data were analyzed using NITPIC, SEDPHAT, and GUSSI for a one-site binding model.
Surface plasmon resonance
Measurements were conducted using a BI-4500A five-channel SPR with autosampler and degasser pump (Biosensing Instrument Inc.) and a Ni-NTA chip. His 6 -tagged PP1a 7-330 (62.5 nM) in 20 mM tris (pH 8.0), 500 mM NaCl, 0.5 mM TCEP, 1 mM MnCl 2 , and 0.005% Tween-20 was loaded onto a Ni 2+ -NTA chip (Biosensing Instrument Inc.) using different loading times (20, 40 , 60, and 80 s) to achieve different PP1 densities on the His 6 -sensor chip in four different channels (channel 1 was the reference channel). G M 64-105 was prepared in the same buffer as PP1a 7-330 using 1:3 serial dilutions (31.25 to 500 nM). Kinetic parameters were determined by curve fitting using Scrubber (BioLogic Software).
Dephosphorylation assay
Rabbit liver glycogen (Sigma-Aldrich, G8876) and rabbit phosphorylase a (Sigma-Aldrich, P1261) were purchased. All assays were carried out at 30°C for 30 min if not otherwise stated. Dephosphorylation of phosphorylase a was performed at a final concentration of 2 mM in reaction buffer [50 mM tris (pH 7.8), 150 mM NaCl, and 1 mM TCEP]. To investigate the effects of the PP1 interactors G M 49-86 , G M 64-105 , NIPP1 158-216 , spinophilin 417-602 , NG1, or NG2 toward phosphorylase a dephosphorylation, the interactors were added at a 10 M excess to PP1 and incubated for 30 min at room temperature before the initiation of the assay. The final concentration of PP1 for the steady-state experiments was 0.2 mM, except for the time point experiment for which 0.04 mM PP1 was used. To test the effect of glycogen on the dephosphorylation of phosphorylase a, glycogen (4 mg/ml) was added to phosphorylase a before the addition of the G M 64-237 :PP1 holoenzyme. The reactions were terminated by the addition of 5× SDS loading buffer, and the samples were boiled (95°C) for 5 min. The samples were analyzed using SDS-PAGE, fixed, and stained with Pro-Q Diamond and Sypro Ruby (Thermo Fisher Scientific) to quantify the phosphor-protein (phosphorylase a) and total proteins, respectively. Gel images were captured using a ChemiDoc MP Imaging system or a Pharos FX Imager (Bio-Rad), and the densitometry of protein bands was analyzed using Image Lab 6.0 (Bio-Rad).
The GST-GYG1:GYS1 complex (final concentration of 0.1 mg/ml) in assay buffer [50 mM tris (pH 7.8), 150 mM NaCl, 1 mM TCEP, and 5% glycerol] was used in all assays. A 10 M excess of G M To test the effect of glycogen, glycogen (4 mg/ml) was added to GYS1 before the addition of the G M 64-237 :PP1 holoenzyme. The reactions were carried out at 30°C and were terminated at different time points (3, 6, 9, 12, 15 , and 30 min) by the addition of 5× SDS loading buffer and boiling at 95°C for 5 min. Samples were analyzed using SDS-PAGE and stained with Sypro Ruby. Dephosphorylation of GYS1 can be readily visualized as a band shift in SDS-PAGE (30) . The relative distance between the GYS1 bands relative to GST-GYG1 was used to assay the dephosphorylation of GYS1. Last, Pro-Q Diamond (Invitrogen), which stains for total phosphorylation, and mass spectrometer analysis were used to confirm the dephosphorylation states of GYS1.
Con A-Sepharose glycogen binding assay Con A-Sepharose (GE Healthcare) beads were used to assay glycogen binding. Fresh Con A beads were washed in Con A buffer [67 mM Hepes (pH 6.8), 0.2 mM CaCl 2 , 10 mM MgCl 2 , 500 mM NaCl, and 4 mM DTT] and incubated with rabbit liver glycogen (50 mg/ml; Sigma-Aldrich, G-8876, 1:1 volume) at 4°C for 1 hour. Glycogenconjugated Con A beads were washed three times with Con A buffer and resuspended as 50% slurry. Con A-glycogen Sepharose beads (30 ml) were incubated with 15 mg of phosphorylase a, G M
64-237
, and PP1a alone and in various combinations thereof in a total volume of 250 ml for 1 hour at 4°C under gentle mixing. The beads were washed three times with Con A buffer (750 ml) and recovered by centrifugation (2000g, 1 min). The supernatant was removed using gel-loading tips, leaving behind the beads that were then incubated with 25 ml of 1 M a-Dmethylglucoside (in Con A buffer) to elute all proteins bound to glycogen. Eluate (10 ml) was carefully transferred to new tubes to avoid contamination with residual beads and analyzed by SDS-PAGE. SDS-PAGE was stained using Sypro Ruby (Invitrogen) for visualization of total proteins.
MS analysis
Samples were separated by SDS-PAGE, and bands were excised and digested with trypsin in 50 mM ammonium bicarbonate overnight at 37°C. Peptides were extracted using 5% formic acid/50% acetonitrile and dried. Peptides were analyzed on a Q-Exactive Plus mass spectrometer (Thermo Fisher Scientific) equipped with an Easy-nLC 1000 (Thermo Fisher Scientific). Raw data were searched using COMET in high-resolution mode (38) , with a precursor mass tolerance of 1 Da, trypsin enzyme specificity with up to three missed cleavages, and carbamidomethylcysteine as fixed modification. Oxidized methionine and phosphorylated serine, threonine, and tyrosine were searched as variable modifications. Probability of phosphorylation site localization was determined by PhosphoRS (39) . Quantification of LC-MS/MS spectra was performed using MassChroQ with retention time alignment for smart quantification (40) .
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